Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation

American Journal of Hematology

Volumn 89, Issue 5, 2014, Pages 470-479

  Langdon, Jacqueline M ^a   Yates, Saiah C ^a   Femnou, Laurette K ^a   Mccranor, Bryan J ^a   Cheadle, Chris ^a   Xue, Qian Li ^a,b   Vaulont, Sophie ^c   Civin, Curt I ^d   Walston, Jeremy D ^a   Roy, Cindy N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c INSTITUT COCHIN   (France)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMETHOL; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; TURPENTINE;

ABSCESS; ACUTE PHASE RESPONSE; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROCYTE PARAMETERS; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; FOOD INTAKE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; IMMUNOPHENOTYPING; INNATE IMMUNITY; IRON STORAGE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; NORMOCHROMIC NORMOCYTIC ANEMIA; PRIORITY JOURNAL; RETICULOCYTE; SPLEEN CELL;

ANEMIA; ANIMALS; DISEASE MODELS, ANIMAL; ERYTHROPOIESIS; FEMALE; HEPCIDINS; IMMUNOPHENOTYPING; INFLAMMATION; IRON; MICE; MICE, INBRED C57BL;

EID: 84898438674     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23670     Document Type: Article

References (53)

1. Anemia WSGoID. Iron Deficiency Anemia Report of a Study group. Switzerland: World Health Organization technical report series; 1959.
2. Ganz T, Nemeth E. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematology/the Education Program of the American Society of Hematology American Society of Hematology 2011;2011:538-542.
3. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-1044.
4. Lee P, Peng H, Gelbart T, et al. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 2005;102:1906-1910.
5. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-1276.
6. Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood 2008;112:4292-4297.
7. Sasu BJ, Cooke KS, Arvedson TL, et al. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 2010;115:3616-3624.
8. Steinbicker AU, Sachidanandan C, Vonner AJ, et al. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood 2011;117:4915-4923.
9. Theurl I, Schroll A, Sonnweber T, et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood 2011;118:4977-4984.
10. Schwoebel F, van Eijk LT, Zboralski D, et al. The effects of the anti-hepcidin Spiegelmer NOX H94 on inflammation-induced anemia in cynomolgus monkeys. Blood 2013;121:2311-2315.
11. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002;99:4596-4601.
12. Roy CN, Mak HH, Akpan I, et al. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 2007;109:4038-4044.
13. Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008;320:1088-1092.
14. Weinstein DA, Roy CN, Fleming MD, et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: Implications for the anemia of chronic disease. Blood 2002;100:3776-3781.
15. Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 2008;40:569-571.
16. Cartwright GE, Lauritsen MA, Jones PJ, et al. The anemia of infection. I. Hypoferremia, hypercupremia, and alterations in porphyrin metabolism in patients. J Clin Invest 1946;25:65-80.
17. Nikolaisen C, Figenschau Y, Nossent JC. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. J Rheumatol 2008;35:380-386.
18. Ripley BJ, Goncalves B, Isenberg DA, et al. Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia. Ann Rheum Dis 2005;64:849-853.
19. Leng S, Chaves P, Koenig K, et al. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: A pilot study. J Am Geriatr Soc 2002;50:1268-1271.
20. Ferry AE, Baliga SB, Monteiro C, et al. Globin gene silencing in primary erythroid cultures. An inhibitory role for interleukin-6. J Biol Chem 1997;272:20030-20037.
21. McCranor BJ, Kim MJ, Cruz NM, et al. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. Blood Cells Mol Dis 2014;52:126-133.
22. Prince OD, Langdon JM, Layman AJ, et al. Late stage erythroid precursor production is impaired in mice with chronic inflammation. Haematologica 2012;97:1648-1656.
23. Lesbordes-Brion JC, Viatte L, Bennoun M, et al. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 2006;108:1402-1405.
24. Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994;368:339-342.
25. McCranor BJ, Langdon JM, Prince OD, et al. Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age. Haematologica 2013;98:1633-1640.
26. Torrance J, Bothwell T. Tissue Iron Stores. New York, NY: Churchill Livingstone; 1980.
27. Yuan JS, Reed A, Chen F, et al. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006;7:85.
28. Fattori E, Cappelletti M, Costa P, et al. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 1994;180:1243-1250.
29. Oldenburg HS, Rogy MA, Lazarus DD, et al. Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6. Eur J Immunol 1993;23:1889-1894.
30. Beaumier DL, Caldwell MA, Holbein BE. Inflammation triggers hypoferremia and de novo synthesis of serum transferrin and ceruloplasmin in mice. Infect Immun 1984;46:489-494.
31. Birgegard G, Caro J. Increased ferritin synthesis and iron uptake in inflammatory mouse macrophages. Scand J Haematol 1984;33:43-48.
32. De Domenico I, Zhang TY, Koening CL, et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 2010;120:2395-2405.
33. Hershko C, Cook JD, Finch CA. Storage iron kinetics. VI. The effect of inflammation on iron exchange in the rat. Br J Haematol 1974;28:67-75.
34. Kondo H, Saito K, Grasso JP, et al. Iron metabolism in the erythrophagocytosing Kupffer cell. Hepatology 1988;8:32-38.
35. Montosi G, Corradini E, Garuti C, et al. Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload. Hepatology 2005;41:545-552.
36. Reissmann KR, Udupa KB. Effect of inflammation on erythroid precursors (BFU-E and CFU-E) in bone marrow and spleen of mice. J Lab Clin Med 1978;92:22-29.
37. Sheikh N, Dudas J, Ramadori G. Changes of gene expression of iron regulatory proteins during turpentine oil-induced acute-phase response in the rat. Lab Invest 2007;87:713-725.
38. Lou DQ, Lesbordes JC, Nicolas G, et al. Iron- and inflammation-induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo. Hepatology 2005;41:1056-1064.
39. Ishibashi T, Kimura H, Uchida T, et al. Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 1989;86:5953-5957.
40. Ishibashi T, Shikama Y, Kimura H, et al. Thrombopoietic effects of interleukin-6 in long-term administration in mice. Exp Hematol 1993;21:640-646.
41. Pagani A, Nai A, Corna G, et al. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood 2011;118:736-746.
42. Bertero MT, Caligaris-Cappio F. Anemia of chronic disorders in systemic autoimmune diseases. Haematologica 1997;82:375-381.
43. Maury CP, Andersson LC, Teppo AM, et al. Mechanism of anaemia in rheumatoid arthritis: Demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro. Ann Rheum Dis 1988;47:972-978.
44. Richardson CL, Delehanty LL, Bullock GC, et al. Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response. J Clin Invest 2013;123:3614-3623.
45. Libregts SF, Gutierrez L, de Bruin AM, et al. Chronic IFN-gamma production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood 2011;118:2578-2588.
46. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006;8 Suppl 2:S3.
47. Chasis JA. Erythroblastic islands: Specialized microenvironmental niches for erythropoiesis. Curr Opin Hematol 2006;13:137-141.
48. Chow A, Huggins M, Ahmed J, et al. CD169(+) macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat Med 2013;19:429-436.
49. Ramos P, Casu C, Gardenghi S, et al. Macrophages support pathological erythropoiesis in polycythemia vera and beta-thalassemia. Nat Med 2013;19:437-445.
50. Theurl I, Aigner E, Theurl M, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: Diagnostic and therapeutic implications. Blood 2009;113:5277-5286.
51. Laftah AH, Sharma N, Brookes MJ, et al. Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice. Biochem J 2006;397:61-67.
52. Sukumaran A, Varghese J, Tamilselvan J, et al. Effects of acute and chronic inflammation on proteins involved in duodenal iron absorption in mice: A time-course study. Br J Nutr 2012;108:1994-2001.
53. Deschemin JC, Vaulont S. Role of hepcidin in the setting of hypoferremia during acute inflammation. PLoS One 2013;8:e61050.